6 assets in Doxorubicin Induced Cardiomyopathy

Therapeutic assets addressing Doxorubicin Induced Cardiomyopathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Adriamycin Doxorubicin Induced Cardiomyopathy	Tanta University	P2	BB (64)
Atorvastatin Doxorubicin Induced Cardiomyopathy	Damanhour University	P2	B (57)
Dapagliflozin Doxorubicin Induced Cardiomyopathy	Tanta University	P2	CCC (53)
Pentoxifylline Doxorubicin Induced Cardiomyopathy	Tanta University	P2	CCC (53)
Telmisartan Doxorubicin Induced Cardiomyopathy	Tanta University	P1/2	CC (47)
Montelukast Doxorubicin Induced Cardiomyopathy	Damanhour University	N/A	D (30)